Single-agent gemcitabine for biliary tract cancers. Study outcomes and systematic review of the literature.
Kiba T, Nishimura T, Matsumoto S, Hatano E, Mori A, Yasumi S, Doi R, Ikai I, Kitano T, Nishimura T, Yoshikawa K, Ishiguro H, Yanagihara K, Doi E, Teramukai S, Fukushima M.
Kiba T, et al.
Oncology. 2006;70(5):358-65. doi: 10.1159/000098109. Epub 2006 Dec 15.
Oncology. 2006.
PMID: 17179730
Review.